Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody

Fischer, Jens A. A., Hueber, Axel J., Wilson, Stacy, Galm, Margarete, Baum, Wolfgang, Kitson, Christopher, Auer, Johannes, Lorenz, Stefan H., Moelleken, Jörg, Bader, Martin, Tissot, Alain C., Tan, Seng‐Lai, Seeber, Stefan, Schett, Georg · 2015 · Arthritis & Rheumatology

Abstract

Objective: Rheumatoid arthritis therapies that are based on inhibition of a single cytokine, e.g., tumor necrosis factor α (TNFα) or interleukin‐6 (IL‐6), produce clinically meaningful responses in only about half of the treated patients. This study was undertaken to investigate whether combined inhibition of TNFα and IL‐17 has additive or synergistic effects in the suppression of mesenchymal cell activation in vitro and inflammation and tissue destruction in arthritis in vivo. Methods: Cultures of human fibroblast‐like synoviocytes (FLS) were stimulated with TNFα, IL‐17, or a combination of both. Single/combined neutralizing antibodies against TNFα and IL‐17 were used to examine in vitro cytokine responses and in vivo development of arthritis and bone and cartilage destruction in TNFα‐transgenic mice. Bispecific anti–TNFα/IL‐17 antibodies were designed, and their potential to block cytokine responses in human FLS was tested. Results: TNFα and IL‐17 had additive/synergistic effects in promoting production of IL‐6, IL‐8, and granulocyte colony‐stimulating factor, as well as matrix metalloproteinases, in FLS. Bispecific anti–TNFα/IL‐17 antibodies showed superior efficacy in blocking cytokine and chemokine responses in vitro. Furthermore, dual versus single inhibition of both cytokines using neutralizing antibodies was more effective in inhibiting the development of inflammation and bone and cartilage destruction in arthritic mice. Conclusion: Combined blockade of TNFα and IL‐17 was more effective than single blockade in inhibiting cytokine, chemokine, and matrix enzyme responses from human mesenchymal cells and in blocking tissue destruction associated with arthritis, and additionally showed a positive impact on rebalance of bone homeostasis. Bispecific anti–TNFα/IL‐17 antibodies may have superior efficacy in the treatment of arthritis and may overcome the limited therapeutic responses obtained with single cytokine neutralization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38896

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 162

Metadata

Authors
Fischer, J. A. A., Hueber, A. J., Wilson, S., Galm, M., Baum, W., Kitson, C., Auer, J., Lorenz, S. H., Moelleken, J., Bader, M., Tissot, A. C., Tan, S., Seeber, S., & Schett, G.
Venue
Arthritis & Rheumatology
Publisher
Wiley
Published
2014-12-27
Volume
67
Issue
1
Pages
51-62
ISSN
  • 2326-5191 (ISSN-L)
  • 2326-5205
OpenAlex
W1564498610
Cited by
162
References
4
FWCI
16.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.